Study of Epstein-Barr virus (EBV) biomarkers in predicting nasopharyngeal carcinoma (NPC) risk in high-risk individuals from multiplex families, defined as families with 2 or more NPC cases. Results from our study will impact clinical management in individuals with high-risk of NPC.